![](https://webarchive.library.unt.edu/web/20170119171141im_/https://cancergenome.nih.gov/PublishedContent/Images/images/TCGA-esophagus2-tcgaimage.jpg)
New Comprensive Study of Esophageal Cancer
A new study by The Cancer Genome Atlas Research Network found genomic differences between the two most common types of esophageal cancer that help place them in the spectrum of cancers from the stomach to the head and neck. Image Credit: Toshinori Hinoue, Ryo Sakai, Peter W. Laird
![Shirley Pepke, Ph.D., posing outdoors with her collaborator, Greg Ver Steeg, Ph.D.](https://webarchive.library.unt.edu/web/20170119171141im_/https://cancergenome.nih.gov/PublishedContent/Images/images/pepke-article.jpg)
Diagnosed With Ovarian Cancer, a Researcher Mined TCGA Data to Study Her Own Disease
Faced the bleak prognosis associated with stage IIIC ovarian cancer, Shirley Pepke, Ph.D., used her computational biology background to study her own cancer in comparison to TCGA data. Pepke has now been in remission for a year. Image Credit: Gus Ruelas/USC
![Cancers Selected For Study map](https://webarchive.library.unt.edu/web/20170119171141im_/https://cancergenome.nih.gov/PublishedContent/Images/SharedItems/Images/TCGA_tcz_cancerstudy_image_enlarge.jpg)
Cancers Selected for Study
The Cancer Genome Atlas researchers are mapping the genetic changes in 33 cancers. Find out which cancers have been selected for study, the criteria for selection and the scientific questions being asked about each cancer.
![](https://webarchive.library.unt.edu/web/20170119171141im_/https://cancergenome.nih.gov/PublishedContent/Images/images/cancers-selected-study-large.jpg)
Program Overview
Explore how The Cancer Genome Atlas works, the components of the TCGA Research Network and TCGA's place in the cancer genomics field in the Program Overview.
-
TCGA in Action
-
December 2016
CASE STUDY: A Researcher Mined TCGA Data to Study Her Own Ovarian Cancer
Faced the bleak prognosis associated with stage IIIC ovarian cancer, Shirley Pepke, Ph.D., used her computational biology background to study her own cancer in comparison to TCGA data. Pepke has now been in remission for a year. Image Credit: Gus Ruelas/USC -
September 2016
CASE STUDY: TCGA Data Leveraged for Developing FDA-Designated Breakthrough Therapy
Pharmaceutical company Loxo Oncology used TCGA data in the research that led them to develop FDA-designated Breakthrough Therapy LOXO-101, a promising new targeted therapy.
More Stories
-
News and Announcements
- January 04, 2017
TCGA study of esophageal cancers finds features that aid in their classification
A new study by The Cancer Genome Atlas Research Network found genomic differences between the two most common types of esophageal cancer that help place them in the spectrum of cancers from the stomach to the head and neck. Image Credit: Toshinori Hinoue, Ryo Sakai, Peter W. Laird - June 06, 2016
Newly launched Genomic Data Commons to facilitate data and clinical information sharing
The Genomic Data Commons (GDC) is a data sharing platform that promotes precision medicine in oncology, and it will host all of the TCGA data.
View All
-
Research Briefs
-
September 2016
Next-Generation Pathology: TCGA Microscope Slides Helped Train an Automated Lung Cancer Diagnostic Tool
Using over 2,000 pathology slides of lung cancer from The Cancer Genome Atlas (TCGA), researchers from Stanford University trained a machine-learning pipeline to create the first computational model that analyzes image features to better predict patient outcomes.
View All
-
Perspectives
-
October 2015
Genomic Contributions to Breast Cancer Disparities
Dr. Tanya Keenan shares her study's findings on the genomic contributions to breast cancer disparities and advocates for inclusion in breast cancer research.
View All